Global Pathological Examination Market, By Type (Digital Pathology, Traditional Pathology), Service (Anatomic Pathology, Surgical Pathology, Cytopathology, Clinical Pathology), Application (Digestive Organ, Other Applications), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Pathological Examination Market
The pathological examination market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 13.78% in the forecast period of 2021 to 2028 and is expected to reach USD 690.53 million by 2028. The rise in the prevalence of chronic diseases among population across the globe is escalating the growth of pathological examination market.
The pathology examination refers to a complex process which involves many steps. It is an important process for the neoplasm, infection or genetic abnormalities. The physician decides on the course of care by analyzing the valuable information generated by the pathology examination. The examination plays a major role in determining the presence or absence of cancer and providing information on selecting the best treatment option.
The rise in the number of cases related to chronic disease and disorders such as chronic lung diseases, cardiac diseases, cancer, type 2 diabetes and stroke and the increasing mortality rate globally due to the respective diseases are the major factors driving the pathological examination market. The emergence of infectious diseases such as COVID-19 and high need to diagnose and treat such health threats accelerate the pathological examination market growth. The extensive use of pathology examination in the healthcare sector as it plays a crucial role in diagnosing the disease and determining the correct course of treatment for the patient and assisting medical professionals in giving the best treatment options. The increasing research and development activities and the increase in investment in these projects also influence the pathological examination market. Additionally, the growth in geriatric population, rising awareness among people regarding the examination, enhancing healthcare infrastructure and increase in healthcare expenditure positively affect the pathological examination market. Furthermore, emergence of digital pathology, technological advancement and new innovations extend profitable opportunities to the pathological examination market players in the forecast period of 2021 to 2028.
On the other hand, lack of skilled and trained healthcare professionals is expected to obstruct the pathological examination market growth. Scarcity of reimbursement policies is projected to challenge the pathological examination market in the forecast period of 2021-2028.
This pathological examination market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on pathological examination market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Pathological Examination Market Scope and Market Size
The pathological examination market is segmented on the basis of type, service and application. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the pathological examination market is segmented into digital pathology and traditional pathology.
- On the basis of service, the pathological examination market is segmented into anatomic pathology, surgical pathology, cytopathology and clinical pathology.
- On the basis of application, the pathological examination market is segmented into digestive organ and other applications.
Global Pathological Examination Market Country Level Analysis
The pathological examination market is analyzed and market size insights and trends are provided by country, type, service and application as referenced above.
The countries covered in the pathological examination market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the pathological examination market because of the advancement in medical research and well-developed healthcare infrastructure. Asia-Pacific is estimated to witness the fastest growth in the forecast period of 2021-2028 due to the wide availability of advanced technologies, favorable reimbursement policies and high purchasing power of people in the region.
The country section of the pathological examination market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The pathological examination market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for pathological examination market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the pathological examination market. The data is available for historic period 2011-2019.
Competitive Landscape and Pathological Examination Market Share Analysis
The pathological examination market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to pathological examination market.
The major players covered in the pathological examination market report are 3DHISTECH Ltd., Healio, Abbott Pathology, NeoGenomics Laboratories, Inc., F. Hoffmann-La Roche Ltd, Bio SB, Agilent Technologies, Inc., Quest Diagnostics Incorporated, Siemens Healthcare Private Limited, Trinity Biotech, Sonic Healthcare, Diagnostic Pathology Services, Q2 Solutions, HSRL Holdings LLC, BioGenex., Diapath S.p.A., BD, Abcam plc, Merck KGaA, Danaher among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.